Now, more than ever, it is imperative to ensure that you are obtaining the highest quality patents in the most efficient manner. The days of using gut instinct to drive patent prosecution decision-making are long gone. To compete in today’s world, you need accurate, reliable data that provides valuable insight to help manage expectations and drive strategy throughout the prosecution process.
The panel will focus on trends in patent eligibility (35 U.S.C. 101) and claim language (35 U.S.C. 112). With examples from both the life sciences and high-tech sectors, we will walk through amendments made during prosecution and through allowance, looking at language added to overcome examiner rejections. We will also discuss claiming strategies, drafting strategies, and an uptick in 112(a) and (b) rejections, and what this means for prosecution budgets and strategies for streamlining prosecution in light of current trends.
Joining Gene Quinn, patent attorney, President, and CEO of IPWatchdog, on Tuesday, November 30, at 2 PM ET, for the discussion on trends in patent prosecution will be Roberta Young, Counsel at Seyfarth Shaw LLP, Aparna Nemlekar, Partner at Fox Rothschild LLP, and Megan McLoughlin, Product Director at LexisNexis Intellectual Property Solutions.
During the webinar, we will discuss how to:
- Accurately predict and better manage expectations around cost and time of prosecution
- Adjust your prosecution strategy based on USPTO examiner type
- Easily access the patent prosecution analytics you rely on directly in the USPTO PAIR website
- Overturn examiner’s specific rejections with carefully curated ex parte appeals data